Latest News & Features
Americas
The IP specialist bypassed vendors and turned to its own ‘tech geeks’ to create an in-house AI solution for drafting patent applications. LSIPR meets the attorney coders doing it for themselves. 3 April 2025
Europe
The pressures of IP law can take a serious toll on mental wellbeing. Boult Wade Tennant partner and WIPR Diversity Champion, Susi Fish, shares her experiences and tips for managing stress. 3 April 2025
Americas
Lawsuits against pharmacies in seven states aim to protect its flagship Mounjaro and Zepbound medications | Growing competition and patent expiration increase urgency for Lilly | New Jersey and Delaware stores accused of selling unapproved tirzepatide-based products. 3 April 2025
Americas
MSD, Novartis and Eli Lilly are among those whose multi-billion-dollar patents are hurtling towards expiration, writes Marisa Woutersen. 1 April 2025
Careers
Leading patent litigator who worked on disputes involving Broadcom, Sonos, and Tesla joins firm’s Düsseldorf office from EIP. 1 April 2025
Europe
With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its blockbuster blood thinner from generics. Marisa Woutersen finds Bayer’s outside litigation counsel ready for anything. 31 March 2025
Americas
Both parties write to district court hours after Court of Appeals denies rehearing | MSN maintains that the Entresto patent should be delisted from the Orange Book | Novartis urges injunction to block generic version of heart treatment before regulatory gap closes. 27 March 2025
Europe
Advocate general recommends upholding €60.48 million fine against Teva and Cephalon for anti-competitive modafinil settlement. 27 March 2025
Careers
Combining USPTO work with a background in molecular biology, immunology, and plant biochemistry, the new counsel brings patent practitioner and examiner skills to the firm. 27 March 2025
Americas
Court of Appeals rules defence costs in Hatch-Waxman cases are deductible as ordinary business expenses | US IRS stands to pay tax rebate to generics manufacturer. 25 March 2025